Your browser doesn't support javascript.
loading
Population PK/PD modeling of eltrombopag in healthy volunteers and patients with immune thrombocytopenic purpura and optimization of response-guided dosing.
Hayes, Siobhan; Ouellet, Daniele; Zhang, Jianping; Wire, Mary B; Gibiansky, Ekaterina.
Affiliation
  • Hayes S; ICON Development Solutions, Ellicott City, Maryland, USA. Siobhan.hayes@iconplc.com
J Clin Pharmacol ; 51(10): 1403-17, 2011 Oct.
Article in En | MEDLINE | ID: mdl-21148042
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyrazoles / Benzoates / Purpura, Thrombocytopenic, Idiopathic / Hydrazines Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: J Clin Pharmacol Year: 2011 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyrazoles / Benzoates / Purpura, Thrombocytopenic, Idiopathic / Hydrazines Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: J Clin Pharmacol Year: 2011 Document type: Article Affiliation country: Country of publication: